Everything important about our purpose and mission, the business and the people who shape CompuGroup Medical.
Purpose & Mission
Information, downloads and contacts for representatives of press and other media.
We promote dialog in the healthcare sector and ensure that costs are saved in a meaningful way. Everyone should benefit from medical progress with the help of IT.
Koblenz: CompuGroup Medical SE & Co. KGaA (CGM), a worldwide leading e-health company, acquires a 20 percent stake in the Italian-based New Line RdM Società Benefit S.p.A. (New Line), thereby strengthening its position in the Italian healthcare data market. The investment represents the first step of entering international markets for innovative data solutions.
Founded in 1981, New Line provides customer-specific pharmacy consumption market analyses for major drug distributors, cooperatives, chains of pharmacies, parapharmacies and e-commerce companies. An experienced player in the analysis of pharmacy market data, New Line has expanded its panel of pharmacies in recent years to currently more than 12,000. This has led to a significantly increased customer base, both among pharmaceutical companies and among consumer health and personal care companies.
Having partnered with New Line for several years, CGM is expanding its exposure to data-driven solutions on an international scale. This transaction is another proof point underpinning CGM’s ambition to become a leading European health data service provider, following the acquisition of INSIGHT Health in May 2022.
Gabriele Pierani, President and CEO of New Line, states: “CGM becoming a shareholder of New Line is testimony to the potential of our innovative data-based solutions. This partnership will allow us to continue our strong growth, with the entry into new markets, both in Italy and in Europe. We are looking forward to collaborating with INSIGHT Health and CGM to provide added value for our multinational customers.”
Eckart Pech, Managing Director Consumer and Health Management Information Systems in CGM, notes: "We are taking the next step in expanding our strategic position in data-based solutions for healthcare. Our investment in New Line gives us access to the pharmaceutical market in Italy, enabling a more comprehensive coverage of the European healthcare market.”